Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Journal of Neurology|November 24, 2022
Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohortAnn-Katrin Schild, Yasemin Goereci, Daniel Scharfenberg, et al.
Plos Pathogens|April 26, 2014
JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variantsEmilie Sundqvist, Dorothea Buck, Clemens Warnke, et al.
Acta Physiologica (Oxford, England)|January 28, 2026
Functional Training Mitigates Reduced Circulating Indole-3-Lactate Levels in Persons With Relapsing-Remitting Multiple SclerosisTiffany Wences Chirino, Frederike Adammek, Sergen Belen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 15, 2021
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, et al.
JAMA Neurology|April 30, 2019
Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple SclerosisChristiane Gasperi, Anke Salmen, Gisela Antony, et al.
Journal of Neuroimmunology|July 19, 2022
Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif™) using B cell receptor repertoire analysisLinda van der Weele, Sabrina Pollastro, Barbera D C van Schaik, et al.
JAMA Neurology|October 7, 2024
Directly Isolated Allogeneic Virus-Specific T Cells in Progressive Multifocal LeukoencephalopathyNora Möhn, Lea Grote-Levi, Mike P Wattjes, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2014
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSFClemens Warnke, Mark Stettner, Vera Lehmensiek, et al.
JCI Insight|June 8, 2018
Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patientsMarsilio Adriani, Petra Nytrova, Cyprien Mbogning, et al.
Annals of Neurology|April 15, 2014
Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathyClemens Warnke, Gloria von Geldern, Philipp Markwerth, et al.
Pageof 13